<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Smith RJ</submitter><funding>Bill and Melinda Gates Foundation</funding><funding>Wellcome Trust</funding><pagination>102002</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9841287</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>4(1)</volume><pubmed_abstract>Here, we provide a protocol using chemical pulldown combined with mass spectrometry (LC-MS/MS) to identify drug targets in Plasmodium falciparum. This approach works upon the principle that a resin-bound inhibitor selectively binds its molecular target(s) in cell-free lysates. We describe the preparation of drug beads and P. falciparum lysate, followed by chemical pulldown, sample fractionation, and LC-MS/MS analysis. We then detail how to identify specifically bound proteins by comparing protein enrichment in DMSO-treated relative to drug-treated lysates via quantitative proteomics. For complete details on the use and execution of this protocol, please refer to Milne et al. (2022).&lt;sup>1&lt;/sup>.</pubmed_abstract><journal>STAR protocols</journal><pubmed_title>Chemical pulldown combined with mass spectrometry to identify the molecular targets of antimalarials in cell-free lysates.</pubmed_title><pmcid>PMC9841287</pmcid><funding_grant_id>218448/Z/19/Z</funding_grant_id><funding_grant_id>105021/Z/14/Z</funding_grant_id><funding_grant_id>203134/Z/16/Z</funding_grant_id><pubmed_authors>Dey G</pubmed_authors><pubmed_authors>Wyllie S</pubmed_authors><pubmed_authors>Lopez VC</pubmed_authors><pubmed_authors>Syed AJ</pubmed_authors><pubmed_authors>Milne R</pubmed_authors><pubmed_authors>Patterson S</pubmed_authors><pubmed_authors>Wiedemar N</pubmed_authors><pubmed_authors>Smith RJ</pubmed_authors></additional><is_claimable>false</is_claimable><name>Chemical pulldown combined with mass spectrometry to identify the molecular targets of antimalarials in cell-free lysates.</name><description>Here, we provide a protocol using chemical pulldown combined with mass spectrometry (LC-MS/MS) to identify drug targets in Plasmodium falciparum. This approach works upon the principle that a resin-bound inhibitor selectively binds its molecular target(s) in cell-free lysates. We describe the preparation of drug beads and P. falciparum lysate, followed by chemical pulldown, sample fractionation, and LC-MS/MS analysis. We then detail how to identify specifically bound proteins by comparing protein enrichment in DMSO-treated relative to drug-treated lysates via quantitative proteomics. For complete details on the use and execution of this protocol, please refer to Milne et al. (2022).&lt;sup>1&lt;/sup>.</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Mar</publication><modification>2026-04-08T12:29:05.748Z</modification><creation>2025-02-19T03:27:33.456Z</creation></dates><accession>S-EPMC9841287</accession><cross_references><pubmed>36609153</pubmed><doi>10.1016/j.xpro.2022.102002</doi></cross_references></HashMap>